Galena Biopharma (GALE)
Add to Watchlists Create an Alert
2.58
+0.08 +3.20%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Galena Biopharma Revenue Quarterly:
0.00 for Dec. 31, 2012Galena Biopharma Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.00 |
| Sept. 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | 0.00 |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| Dec. 31, 2009 | 0.00 |
| Sept. 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
GALE Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| AVEO Pharmaceuticals | 0.323M |
| Achillion Pharmaceuticals | 0.00 |
| InterMune | 10.53M |
GALE Revenue Quarterly Rankings
| Overall |
36th percentile 5057 of 8006 |
| Sector |
20th percentile 547 of 686 in Healthcare |
| Industry |
33rd percentile 165 of 248 in Biotechnology |
GALE Revenue Quarterly Range, Past 5 Years
| Minimum | 0.00 | Mar 2009 |
| Maximum | 0.00 | Mar 2009 |
| Average | 0.00 |
